Viktor Steimle » Autres publications

Grueter, B., Petter, M., Egawa, T., Laule-Kilian, K., Aldrian, CJ., Wuerch, A., Ludwig, Y., Fukuyama, H., Wardemann, H., Waldschuetz, R., Möröy, T., Taniuchi, I., Steimle, V., Littman, DR., and Ehlers, M. (2005). Runx3 regulates integrin alphaE/CD103 and CD4 expression during development of CD4-/CD8+ T cells. J Immunol, 175, 1694-705.

Camacho-Carvajal, M. M., Klingler, S., Schnappauf, F., Hake, S. B., and Steimle, V. (2004). Importance of class II transactivator leucine-rich repeats for dominant-negative function and nucleo-cytoplasmic transport. Int Immunol 16, 65-75.

Camacho-Carvajal, M. M., Wollscheid, B., Aebersold, R.,Steimle, V., and Schamel, W. W. (2004). Two-dimensional Blue native/SDS gel electrophoresis of multi-protein complexes from whole cellular lysates: a proteomics approach. Mol Cell Proteomics 3, 176-182.

Ehlers, M., Laule-Kilian, K., Petter, M., Aldrian, C. J., Grueter, B., Wurch, A., Yoshida, N., Watanabe, T., Satake, M., and Steimle, V. (2003). Morpholino antisense oligonucleotide-mediated gene knockdown during thymocyte development reveals role for Runx3 transcription factor in CD4 silencing during development of CD4-/CD8+ thymocytes. J Immunol 171, 3594-3604.

Hake, S. B., Tobin, H. M., Steimle, V., and Denzin, L. K. (2003). Comparison of the transcriptional regulation of classical and non-classical MHC class II genes. Eur J Immunol 33, 2361-2371.

Schnappauf, F., Hake, S. B., Camacho Carvajal, M. M., Bontron, S., Lisowska-Grospierre, B., and Steimle, V. (2003). N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA. Eur J Immunol 33, 2337-2347.

Otten, L. A., Tacchini-Cottier, F., Lohoff, M., Annunziato, F., Cosmi, L., Scarpellino, L., Louis, J., Steimle, V., Reith, W., and Acha-Orbea, H. (2003). Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes. J Immunol 170, 1150-1157.

Hake, S. B., Masternak, K., Kammerbauer, C., Janzen, C., Reith, W., and Steimle, V. (2000).CIITA leucine-rich repeats control nuclear localization, In vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Mol Cell Biol 20, 7716-7725.

Masternak, K., Muhlethaler-Mottet, A., Villard, J., Zufferey, M., Steimle, V., and Reith, W. (2000). CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev 14, 1156-1166.

Viktor Steimle » Autres publications